drugset / Trial / NCT00094757
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus.
Timeline
- Start
- 2004-10-06
- Primary completion
- 2005-08-17
- Completion
- 2006-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |
| Subject | Sitagliptin | Small molecule | 200 mg | Oral |